Why the study?
Patients with end-stage renal disease were excluded from most studies, leaving no unambiguous answers regarding the diagnosis and management of myocardial infarction in those on chronic hemodialysis.
There is a significant evidence gap in the diagnosis and management of myocardial infarction in patients with end-stage renal disease on hemodialysis.
MI management in hemodialysis patients lacks evidence-based guidance; leaves open the need for dedicated inclusive trials.
This review represents different aspects of myocardial infarction in patient with end - stage renal disease on chronic hemodialysis. We discuss difficulties in diagnosis, optimal method of coronary revascularization, timing of hemodialysis session, medical therapy, as well as epidemiology and prognosis. There are no unambiguous answers to these problems because patients with end - stage renal disease were excluded from most of the studies.
No takes yet. Share an insight, caveat, or question.
Antukh et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: